Compare CYTK & WMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | WMS |
|---|---|---|
| Founded | 1997 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 10.2B |
| IPO Year | 2004 | 2014 |
| Metric | CYTK | WMS |
|---|---|---|
| Price | $69.27 | $135.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 19 | 8 |
| Target Price | $89.26 | ★ $180.63 |
| AVG Volume (30 Days) | ★ 1.7M | 977.5K |
| Earning Date | 05-05-2026 | 05-21-2026 |
| Dividend Yield | N/A | ★ 0.49% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 5.44 |
| Revenue | $13,368,000.00 | ★ $3,050,376,000.00 |
| Revenue This Year | $7.37 | $5.23 |
| Revenue Next Year | $310.19 | $12.79 |
| P/E Ratio | ★ N/A | $23.81 |
| Revenue Growth | N/A | ★ 5.03 |
| 52 Week Low | $31.99 | $109.63 |
| 52 Week High | $80.20 | $179.32 |
| Indicator | CYTK | WMS |
|---|---|---|
| Relative Strength Index (RSI) | 45.21 | 44.00 |
| Support Level | $59.07 | $131.89 |
| Resistance Level | $70.69 | $146.04 |
| Average True Range (ATR) | 2.87 | 3.75 |
| MACD | -1.15 | -0.08 |
| Stochastic Oscillator | 25.26 | 28.83 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Advanced Drainage Systems Inc is the manufacturer of water management solutions in the stormwater and onsite septic wastewater industries, providing superior drainage solutions for use in the construction and agriculture marketplaces. Its products are used across a broad range of end markets and applications, including residential, non-residential, infrastructure and agriculture applications. It operates business in three distinct reportable segments: Pipe; International, and Infiltrator. It generates a greater proportion of revenue from its Pipe segment, which consists of Pipe product sales in the United States. The Infiltrator is a provider of plastic leachfield chambers and systems, septic tanks and accessories, for use in residential applications.